-
公开(公告)号:US09771411B2
公开(公告)日:2017-09-26
申请号:US14664290
申请日:2015-03-20
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: Stuart Emanuel , Linda Engle , Ray Camphausen , Martin C. Wright , Ginger Chao Rakestraw , Marco Gottardis , Joan Carboni
IPC: A61K38/16 , A61K38/39 , C07K14/435 , C07K14/475 , C07K14/78 , C07K16/28 , A61K39/395 , A61K45/06 , C07K14/705 , A61K39/00
CPC classification number: C07K14/78 , A61K38/39 , A61K39/3955 , A61K45/06 , A61K2039/505 , C07K14/475 , C07K16/2863 , C07K2317/31 , C07K2317/34 , C07K2317/92 , C07K2318/20 , C07K2319/30
Abstract: The present invention relates to bispecific molecules comprising an EGFR binding domain and a distinct IGFIR binding domain for use in diagnostic, research and therapeutic applications. The invention further relates to cells comprising such proteins, polynucleotide encoding such proteins or fragments thereof, and vectors comprising the polynucleotides encoding the innovative proteins. Exemplary bispecific molecules include antibody-like protein dimers based on the tenth fibronectin type III domain.
-
公开(公告)号:US11344639B2
公开(公告)日:2022-05-31
申请号:US16305284
申请日:2017-05-31
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: Paul E. Morin , David Donnelly , Dasa Lipovsek , Jochem Gokemeijer , Maria Jure-Kunkel , David Fabrizio , Martin C. Wright , Douglas Dischino , Samuel J. Bonacorsi, Jr. , Ralph Adam Smith , Virginie Lafont , Daniel Cohen , David K. Leung
Abstract: Provided herein are novel 10Fn3 domains which specifically bind to PD-L1, as well as imaging agents based on the same for diagnostics.
-
公开(公告)号:US10406251B2
公开(公告)日:2019-09-10
申请号:US15529260
申请日:2015-11-24
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: Paul E. Morin , David Donnelly , Dasa Lipovsek , Jochem Gokemeijer , Maria N. Jure-Kunkel , David Fabrizio , Martin C. Wright , Douglas Dischino , Samuel J. Bonacorsi, Jr. , Ralph Adam Smith , Virginie Lafont , Daniel Cohen
IPC: A61K51/08 , C07K14/78 , G01N33/60 , G01N33/68 , G01N33/574
Abstract: Provided herein are novel polypeptides comprising fibronectin type III tenth (10Fn3) domains which specifically bind to Programmed Death Ligand-1 (PD-L1), as well as imaging agents based on the same for diagnostics.
-
-